These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Genotypes, carbapenemase carriage, integron diversity and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Author: Bocharova Y, Savinova T, Lazareva A, Polikarpova S, Gordinskaya N, Mayanskiy N, Chebotar I.
    Journal: Int J Antimicrob Agents; 2020 Apr; 55(4):105899. PubMed ID: 31931151.
    Abstract:
    Pseudomonas aeruginosa is a serious opportunistic pathogen demonstrating a high level of resistance to many groups of antibiotics, including carbapenems. This study aimed to characterise the molecular epidemiology and prevalence of mobile genetic elements associated with resistance to carbapenems among P. aeruginosa (CRPA) clinical isolates. Among 145 carbapenem-resistant P. aeruginosa isolates, 34 different sequence types (STs) were detected; the six most common STs were ST654 (24%), ST235 (24%), ST111 (8%), ST446 (6%), ST357 (5%) and ST2592 (a novel single-locus variant of ST357) (4%). A carbapenemase gene was found in 94 isolates (64.8%). The blaVIM-2 gene was harboured by 64 isolates (44.1%) restricted to ST111, ST235 and ST654, and the blaGES-type and blaOXA-10 group genes were each detected in 15 isolates (10.3%); none of other tested carbapenemase genes, including blaIMP, blaNDM and blaGIM, were detected. Among the blaVIM-2-positive isolates, five types of blaVIM-2-containing integrons were discovered, including In56, In559, In59-like, In59 and In249. The oprD gene was disrupted by an insertion sequence (IS) in 15.9% of isolates. Overall, five types of IS elements were found (ISPsme1, ISPa1328, ISPa26, ISPst2 and ISPa195). Observed rearrangements within variable regions of blaVIM-2-carrying integrons in conjunction with the discovery of a novel type of oprD-disrupting IS element illustrate the ongoing evolution of CRPA a, which warrants further investigation.
    [Abstract] [Full Text] [Related] [New Search]